In the present paper we aim to explore the efficiency of a new mTHPC formulation that uses HSA to disperse the drug in solution and to investigate the mechanism that triggers inhibition of cancer cells viability in two HNSCC cell lines upon PDT treatment. Here, ALB is linked to head and neck squamous cell carcinoma.